Replies to post #365853 on Amarin Corp Plc (AMRN)

[CaptBeer]

That's right. Unfortunately, Judge Andrews ruled that this case was not like GSK v. TEVA but more like Grunenthal.

"In that case, the district court made a factual determination that this label did not instruct the claimed method. We found no clear error in the district court’s finding of no inducement because the generic labels did not “implicitly or explicitly encourage or instruct users to take
action that would inevitably lead to . . . treatment of polyneuropathic
pain.”

[ziploc_1]

IMO the majority of patients taking Lovaza...are taking it for the CVD indication...e.g. my barber was taking Lovaza because he had had a stroke...When he had another stroke, I advised him to ask his Doc to switch his prescription to Vascepa.

Teva is the seller of generic Lovaza and they have a good share of the CVD market, which should be Vascepa's.